Human pegivirus challenge: detection and molecular characterization in HCV/HIV coinfected individuals

J. Pereira, J. J. Barros, C. Brandão, V. Paula, C. C. Soares
{"title":"Human pegivirus challenge: detection and molecular characterization in HCV/HIV coinfected individuals","authors":"J. Pereira, J. J. Barros, C. Brandão, V. Paula, C. C. Soares","doi":"10.35259/ISI.SACT.2019_32865","DOIUrl":null,"url":null,"abstract":"is rare. Objective: The aim of this study was to determine the prevalence and genotypic distribution of HPgV in patients attended at a hospital in Rio de Janeiro. Methodology : A RT-PCR assay for specific amplification of 5´UTR region of HPgV genome was performed in 174 serum samples collected from patients under health treatment at a hospital in Rio de Janeiro. The samples were classified into three groups: 56 samples form HCV/HIV coinfected individuals; 58 from HCV mono-infected and 60 from HIV monoinfected individuals. All positive samples were submitted to direct sequencing for genotyping and molecular characterization. Results: The overall prevalence of HPgV-1 was 17.2% (30/174). Among HCV/HIV coinfected patients, HPgV prevalence was 14.3% (8/56), and all of them were successfully sequenced. Phylogenetic analysis revealed the presence of genotypes 2a (12.5%), 2b (62.5%) and 3 (25%). HPgV was also found in coinfection with HCV (8.6%; 5/58) and HIV (28.3%; 17/60). Conclusion : Our findings demonstrate the high frequency of HPgV among HCV/HIV coinfected, HCV and HIV monoinfected individuals attending a public hospital in Rio de Janeiro. Circulating HPgV genotypes described here have already been reported in past Brazilian studies, but this is the first data about HCV/HIV patients in Rio de Janeiro city. This study intends to contribute with insights about epidemiological characteristics and impact (if there is any) of HPgV in the natural course of HCV and/ or HIV infection.","PeriodicalId":427855,"journal":{"name":"Anais do IV International Symposium on Immunobiological e VII Seminário Anual Científico e Tecnológico de Bio-Manguinhos","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anais do IV International Symposium on Immunobiological e VII Seminário Anual Científico e Tecnológico de Bio-Manguinhos","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35259/ISI.SACT.2019_32865","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

is rare. Objective: The aim of this study was to determine the prevalence and genotypic distribution of HPgV in patients attended at a hospital in Rio de Janeiro. Methodology : A RT-PCR assay for specific amplification of 5´UTR region of HPgV genome was performed in 174 serum samples collected from patients under health treatment at a hospital in Rio de Janeiro. The samples were classified into three groups: 56 samples form HCV/HIV coinfected individuals; 58 from HCV mono-infected and 60 from HIV monoinfected individuals. All positive samples were submitted to direct sequencing for genotyping and molecular characterization. Results: The overall prevalence of HPgV-1 was 17.2% (30/174). Among HCV/HIV coinfected patients, HPgV prevalence was 14.3% (8/56), and all of them were successfully sequenced. Phylogenetic analysis revealed the presence of genotypes 2a (12.5%), 2b (62.5%) and 3 (25%). HPgV was also found in coinfection with HCV (8.6%; 5/58) and HIV (28.3%; 17/60). Conclusion : Our findings demonstrate the high frequency of HPgV among HCV/HIV coinfected, HCV and HIV monoinfected individuals attending a public hospital in Rio de Janeiro. Circulating HPgV genotypes described here have already been reported in past Brazilian studies, but this is the first data about HCV/HIV patients in Rio de Janeiro city. This study intends to contribute with insights about epidemiological characteristics and impact (if there is any) of HPgV in the natural course of HCV and/ or HIV infection.
人类培吉病毒攻击:HCV/HIV合并感染个体的检测和分子特征
是罕见的。目的:本研究的目的是确定在里约热内卢一家医院就诊的患者中hpv的患病率和基因型分布。方法:采用RT-PCR方法对从里约热内卢一家医院接受健康治疗的患者收集的174份血清样本进行hpv基因组5´UTR区域特异性扩增。样本分为三组:HCV/HIV合并感染者56例;58例来自单一HCV感染者,60例来自单一HIV感染者。所有阳性样品提交直接测序进行基因分型和分子鉴定。结果:hpv -1的总患病率为17.2%(30/174)。在HCV/HIV合并感染患者中,hpv患病率为14.3%(8/56),所有患者均成功测序。系统发育分析显示存在基因型2a(12.5%)、2b(62.5%)和3(25%)。hpv与HCV合并感染中也发现了hpv (8.6%;5/58)和艾滋病毒(28.3%;17/60)。结论:我们的研究结果表明,在里约热内卢一家公立医院就诊的HCV/HIV合并感染者、HCV和HIV单感染者中,hpv的发病率很高。在过去的巴西研究中已经报道了这里描述的循环hpv基因型,但这是里约热内卢市HCV/HIV患者的第一次数据。本研究旨在深入了解hpv在HCV和/或HIV感染的自然过程中的流行病学特征和影响(如果有的话)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信